Parenteral non-systemic administration of buffers to inhibit solid tumors, hyperpigmentation and metastasis of gout

摘要

Parenteral administration (except for direct systemic administration) of the present invention, alone or in combination with a pH-increasing agent or other metastasis inhibitor, is effective and overcomes the disadvantages of intravenous and oral administration in the treatment of solid tumors, scleroderma and gout.